Bray Capital Advisors Has $1.81 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Bray Capital Advisors reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 28.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,662 shares of the financial services provider’s stock after selling 5,329 shares during the quarter. Bray Capital Advisors’ holdings in iShares Biotechnology ETF were worth $1,806,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $29,000. Highline Wealth Partners LLC bought a new stake in iShares Biotechnology ETF in the 3rd quarter valued at $30,000. HHM Wealth Advisors LLC boosted its stake in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $33,000. Finally, Hager Investment Management Services LLC bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $34,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

IBB opened at $139.43 on Friday. The business has a fifty day simple moving average of $135.56 and a 200 day simple moving average of $140.78. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.